Novavax Inc.

(NVAX)

By |

Profile

Novavax Inc is a clinical-stage vaccine company engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

Contact Information

Website: www.novavax.com
Main Phone: +1 240 268-2000
Address: 20 Firstfield Road
State: MD
City / Town: Garthersburg
Country: USA
Postal Code: 20878

Issuer Information

Exchange: NGS
Employees: 443
NAICS: Biological Produ
$ 1.45 $ 0.15 (12.02%)
Last Price 1.45 Change $ 0.16 Change % 12.02 Tick N/A
Bid 1.44 Bid Size 30,200.00 Ask 1.45 Ask Size 37,600.00
Open 1.30 High 1.48 Low 1.26 Prev Close 1.29
Last Trade Volume 11.7 mi 52 Wk Hi 8.95 52 Wk Low 1.16
Market Cap 392 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 271,245,967.00 EPS (TTM) -1.12 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 17
Number of Buys 1 10
Number of Sells 1 7
Net Activity -18576 -58526
Last 10 Buys Shares
Barclay A. Phillips 1,000
Stanley Charles Erck 1,000
John A. Herrmann 1,000
Barclay A. Phillips 1,000
Gregory Glenn 1,000
John Trizzino 1,000
John A. Herrmann 1,000
Gregory Glenn 1,000
John Trizzino 1,000
Barclay A. Phillips 1,000
Last 10 Sell Shares
Gary C. Evans 1,000
Gary C. Evans 1,000
Gary C. Evans 1,000
Stanley Charles Erck 1,000
Stanley Charles Erck 1,000
Gregory Glenn 1,000
John A. Herrmann 1,000
Gary C. Evans 1,000
Barclay A. Phillips 1,000
Barclay A. Phillips 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 17 17 17 17
Low Target Price Estimate 5.75 5.75 5.75 5.75
Mean Target Price Estimate 12.98 13.15 13.15 12.98
Standard Deviation 4.24 3.81 3.81 4.24
Date of Most Recent Estimate 08/11/16 06/27/16 06/27/16 08/23/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 5 5 6
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.33 1.33 1.29